ClinConnect ClinConnect Logo
Search / Trial NCT06613646

The Importance of Pectoralis Minor Syndrome in Hemiplegic Shoulder Pain

Launched by ISTANBUL UNIVERSITY - CERRAHPASA · Sep 25, 2024

Trial Information

Current as of July 12, 2025

Active, not recruiting

Keywords

Pectoralis Minor Syndrome Ultrasound Guided Injections Hemiplegia Hemiplegic Shoulder Pain

ClinConnect Summary

This clinical trial is studying a condition called hemiplegic shoulder pain, which is common in people who have had a stroke. This type of pain often happens because of muscle weakness or problems with the joints and nerves. The researchers are particularly interested in a muscle called the pectoralis minor, as they believe it may play a significant role in causing this shoulder pain. By understanding how this muscle affects pain levels, the study aims to improve treatment and rehabilitation strategies for those experiencing hemiplegic shoulder pain.

To participate in the trial, individuals must be between 65 and 74 years old, have developed spastic hemiplegia (which means one side of their body is weak) due to a stroke, and experience shoulder pain on the affected side. However, certain conditions would exclude someone from participating, such as being unable to communicate, having severe sensitivities, or having undergone certain surgeries. Participants can expect to contribute to important research that may lead to better management of shoulder pain in stroke patients, helping healthcare providers offer more effective treatment options in the future.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Development of spastic hemiplegia due to stroke
  • Presence of shoulder pain on the hemiplegic side
  • Exclusion Criteria:
  • Lack of medical stability
  • Inability to communicate verbally
  • History of severe sensitivity to lidocaine injections
  • Surgical history related to the hemiplegic shoulder
  • Presence of a prosthesis in the hemiplegic shoulder
  • Malignancy in the hemiplegic shoulder
  • Severe psychiatric illness
  • History of injections to the hemiplegic shoulder within the last 6 months
  • Pregnancy
  • History of inflammatory rheumatic disease

About Istanbul University Cerrahpasa

Istanbul University - Cerrahpasa is a prestigious academic institution renowned for its commitment to advancing medical research and education. With a focus on innovative clinical trials, the university harnesses cutting-edge methodologies to address pressing health challenges. Its collaborative environment fosters interdisciplinary research, enabling the development of effective therapeutic strategies and enhancing patient care. The institution's dedication to ethical standards and patient safety underscores its reputation as a leader in clinical research within the region and beyond.

Locations

Istanbul, , Turkey

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported